Evaluation of visinin-like protein 1 concentrations in the cerebrospinal fluid of patients with mild cognitive impairment as a dynamic biomarker of Alzheimer's disease

Journal of Alzheimer's Disease

Volumn 43, Issue 3, 2015, Pages 1031-1037

  Mroczko, Barbara ^a   Groblewska, Magdalena ^a   Zboch, Marzena ^b   Muszyński, Paweł ^a   Zajkowska, Agata ^a   Borawska, Renata ^a   Szmitkowski, MacIej ^a   Kornhuber, Johannes ^c   Lewczuk, Piotr ^c  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

^b WROCLAW MEDICAL UNIVERSITY   (Poland)

^c UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

Alzheimer's disease; biomarkers; cerebrospinal fluid; mild cognitive impairment; visinin like protein 1

Indexed keywords

AMYLOID BETA PROTEIN[1-40]; AMYLOID BETA PROTEIN[1-42]; BIOLOGICAL MARKER; TAU PROTEIN; UNCLASSIFIED DRUG; VISININ LIKE PROTEIN 1; AMYLOID BETA PROTEIN; NEUROCALCIN; PEPTIDE FRAGMENT; VSNL1 PROTEIN, HUMAN;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DEMENTIA; DISEASE ASSOCIATION; DISEASE MARKER; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MALE; MILD COGNITIVE IMPAIRMENT; NEUROCHEMISTRY; NEUROPSYCHOLOGY; PROTEIN CEREBROSPINAL FLUID LEVEL; VERY ELDERLY; CEREBROSPINAL FLUID; DISEASE COURSE; MIDDLE AGED;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; BIOLOGICAL MARKERS; BIOMARKERS; DISEASE PROGRESSION; FEMALE; HUMANS; MALE; MIDDLE AGED; MILD COGNITIVE IMPAIRMENT; NEUROCALCIN; PEPTIDE FRAGMENTS; TAU PROTEINS;

EID: 84914695113     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-141050     Document Type: Article

References (22)

1. Berridge MJ, Lipp P, BootmanMD(2000) The versatility and universality of calcium signalling. Nat Rev Mol Cell Biol 1, 11-21.
2. Ames JB, Tanaka T, Stryer L, Ikura M (1996) Portrait of a myristoyl switch protein. Curr Opin Struct Biol 6, 432-438.
3. Braunewell KH, Gundelfinger ED (1999) Intracellular neuronal calcium sensor proteins: A family of EF-hand calcium-binding proteins in search of a function. Cell Tissue Res 299, 1-12.
4. Burgoyne RD,Weiss JL (2001) The neuronal calcium sensor family of Ca2+-binding proteins. Biochem J 353, 1-12.
5. Burgoyne RD, O'Callaghan DW, Hasdemir B, Haynes LP, Tepikin AV (2004) Neuronal Ca2+-sensor proteins: Multitalented regulators of neuronal function. Trends Neurosci 27, 203-209.
6. Weiss JL, Hui H, Burgoyne RD (2010) Neuronal calcium sensor-1 regulation of calcium channels, secretion, and neuronal outgrowth. Cell Mol Neurobiol 30, 1283-1292.
7. Lee JM, Blennow K, Andreasen N, Laterza O, Modur V, Olander J, Gao F, Ohlendorf M, Ladenson JH (2008) The brain injury biomarker VLP-1 is increased in the cerebrospinal fluid of Alzheimer's disease patients. Clin Chem 54, 1617-1623.
8. Craig-Schapiro R, Fagan AM, Holtzman DM (2009) Biomarkers of Alzheimer's disease. Neurobiol Dis 35, 128-140.
9. Tarawneh R, D'Angelo G, Macy E, Xiong C, Carter D, Cairns NJ, Fagan AM, Head D, Mintun MA, Ladenson JH, Lee JM, Morris JC, HoltzmanDM(2011)Visinin-like protein-1: Diagnostic and prognostic biomarker in Alzheimer disease. Ann Neurol 70, 274-285.
10. Braunewell K, Riederer P, Spilker C, Gundelfinger ED, Bogerts B, Bernstein HG (2001) Abnormal localization of two neuronal calcium sensor proteins, visinin-like proteins (vilips)-1 and-3, in neocortical brain areas of Alzheimer disease patients. Dement Geriatr Cogn Disord 12, 110-116.
11. Schnurra I, Bernstein HG, Riederer P, Braunewell KH (2001) The neuronal calcium sensor protein VILIP-1 is associated with amyloid plaques and extracellular tangles in Alzheimer's disease and promotes cell death and tau phosphorylation in vitro: A link between calcium sensors and Alzheimer's disease Neurobiol Dis 8, 900-909.
12. Laterza OF, Modur VR, Crimmins DL, Olander JV, Landt Y, Lee JM, Ladenson JH (2006) Identification of novel brain biomarkers. Clin Chem 52, 1713-1721.
13. Paterlini M, Revilla V, Grant AL, Wisden W (2000) Expression of the neuronal calcium sensor protein family in the rat brain. Neuroscience 99, 205-216.
14. Wilmot B, McWeeney SK, Nixon RR, Montine TJ, Laut J, Harrington CA, Kaye JA, Kramer PL (2008) Translational gene mapping of cognitive decline. Neurobiol Aging 29, 524-541.
15. Bernstein HG, Baumann B, Danos P, Diekmann S, Bogerts B, Gundelfinger ED, Braunewell KH (1999) Regional and cellular distribution of neural visinin-like protein immunoreactivities (VILIP-1 and VILIP-3) in human brain. J Neurocytol 28, 655-662.
16. McKhann GM, Knopman DS, Chertkow H, Hyman BT, Jack CR Jr, Kawas CH, Klunk WE, Koroshetz WJ, Manly JJ, Mayeux R, Mohs RC, Morris JC, Rossor MN, Scheltens P, Carrillo MC, Thies B, Weintraub S, Phelps CH (2011) The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 7, 263-269.
17. Albert MS, DeKosky ST, Dickson D, Dubois B, Feldman HH, Fox NC, Gamst A, Holtzman DM, Jagust WJ, Petersen RC, Snyder PJ, Carrillo MC, Thies B, Phelps CH (2011) The diagnosis of mild cognitive impairment due to Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 7, 270-279.
18. Lewczuk P, Zimmermann R, Wiltfang J, Kornhuber J (2009) Neurochemical dementia diagnostics: A simple algorithm for interpretation of the CSF biomarkers. J Neural Transm 116, 1163-1167.
19. Miller JA, Oldham MC, Geschwind DH (2008) A systems level analysis of transcriptional changes in Alzheimer's disease and normal aging. J Neurosci 28, 1410-1420.
20. Gómez Ravetti M, Rosso OA, Berretta R, Moscato P (2010) Uncovering molecular biomarkers that correlate cognitive decline with the changes of hippocampus' gene expression profiles in Alzheimer's disease. PLoS One 5, e10153.
21. Tarawneh R, Lee JM, Ladenson JH, Morris JC, Holtzman DM (2012) CSF VILIP-1 predicts rates of cognitive decline in early Alzheimer disease. Neurology 78, 709-719.
22. Zimmermann R, Beck G, Knispel S, Maler JM, Weih M, Wiltfang J, Kornhuber J, Lewczuk P (2010) Intrathecal IgG synthesis in patients with alterations in the neurochemical dementia diagnostics. J Alzheimers Dis 19, 1199-1203.